510(k) K201256
K201256 is an FDA 510(k) premarket notification submitted by Procise Diagnostics for the device "Procise CRP, ProciseDx Analyzer, ProciseDx Calibration Cartridge". The FDA issued a decision of Substantially Equivalent on November 4, 2022. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 4, 2022
- Date Received
- May 11, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type